DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/t4wv8z/anti_peptic_ulcer) has announced the addition of the "Anti Peptic Ulcer Drugs Markets in China" report to their offering.
China's demand for Anti Peptic Ulcer Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2004, 2009 and 2014) and long-term forecasts through 2019 and 2024 are presented. Major producers in China are profiled.
- Proton Pump Inhibitor
- H2 Receptor Antagonist
- Gastric Mucosal Protective Drugs
- Other Anti Peptic Ulcer Drugs
- Import and Export
Key Topics Covered:
II. BUSINESS ENVIRONMENT
III. ANTI PEPTIC ULCER DRUGS INDUSTRY ASSESSMENTS
IV. ANTI PEPTIC ULCER DRUGS PRODUCTION AND DEMAND
V. ANTI PEPTIC ULCER DRUGS MARKET OUTLOOK
VI. MARKETING STRATEGIES
VII. ANTI PEPTIC ULCER DRUGS PRODUCER DIRECTORY
- Changzhou Siyao Pharmaceutical Co., Ltd
- Nanjing Aosaikang Medicinal Group
For more information visit http://www.researchandmarkets.com/research/t4wv8z/anti_peptic_ulcer